This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
BURLINGTON, Mass., Sept. 25, 2012 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) will host an Analyst Day to update the investment community on the Company, its growth initiatives and strategic priorities. Analyst Day will be held Tuesday, September 25, 2012 at Ruth's Chris Steakhouse, 148 W 51st Street, New York, NY and will begin at 9:30 am EDT and conclude at 12:30pm EDT.
A live audio webcast of the presentation will be available at
http://www.lemaitre.com/investor and will be available for replay for approximately 30 days.
About LeMaitre Vascular
LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart, including the Over-the-Wire LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt and The UnBalloon.
Our principal executive offices are located at 63 Second Avenue, Burlington, Massachusetts 01803. Additional information can be found at
The LeMaitre Vascular, Inc. logo is available at
CONTACT: LeMaitre Vascular, Inc.